Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection

Clinical trial NCT00400322 · COMPLETED

Trial details

NCT number: NCT00400322
Sponsor: Karolinska Institutet
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Glioblastoma Multiforme Cytomegalovirus Infection

Start date: 2006-08-01
Primary completion: 2008-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.